Hevolution commits $8.5 million to support young researchers in multi-year grant program with AFAR
RIYADH, Saudi Arabia, August 31, 2022–(BUSINESS WIRE)–Evolution Foundationa nonprofit organization that provides grants and seed investments to encourage health science research and entrepreneurship, and the American Federation for Aging Research (AWAY) announce an international research grant program to enable early-career researchers to conduct research into therapies and treatments that broaden health.
Representing the Hevolution Foundation’s first capital deployment in aging research, the Hevolution/AFAR New Investigator Awards in Biology of Aging and Geroscience Research will offer up to 18 scholarships over three years of US$375,000 each. The awards will support research projects in the basic biology of aging and/or geroscience, a research paradigm focused on the biology of aging and the biology of age-related diseases. Junior researchers from all over the world are welcome to apply.
“The goal of our grant programs is to advance geroscience globally across the entire R&D value chain, by funding long-term basic research, accelerating the development of new drugs, expanding the therapeutic applications of existing drugs and ensuring that innovations in the field are available to everyone around the world,” commented Felipe Sierra, PhD, Chief Scientific Officer of the Hevolution Foundation. “A fundamental part of this is the support of young researchers, and we are delighted to work with AFAR on this new initiative.”
In addition, the Hevolution Foundation will establish a conference fund, managed by AFAR, to support scientific conferences and meetings on research in aging and geroscience.
Dr. Sierra concluded: “This collaboration with AFAR is the first of many agreements and partnerships that we hope to form with leading institutions and organizations in the field of aging and geroscience research worldwide. . With such funding, we intend to catalyze the field, enable its growth, and accelerate progress.”
Recipients of the New Investigator Award will be chosen through a rigorous peer review process. Applications will be reviewed by established aging researchers who volunteer their time and expertise to select scientists and research projects most likely to make meaningful contributions to helping us stay healthy longer as we age. . AFAR and the Hevolution Foundation plan to announce the winners in the coming months.
For more information on the New Investigator Awards in Aging Biology and Geroscience, the Conference Fund, and all AFAR grant programs, please visit http://www.afar.org/funding-opportunities.
About the Hevolution Foundation
Founded on the belief that every person has the right to live a longer and healthier life, the Hevolution Foundation is a global catalyst, partner and convener, whose mission is to drive efforts to extend lifespan. healthy human and to understand the processes of aging. By focusing on aging as a treatable process, the Hevolution Foundation aims to increase the number of aging-related treatments on the market, reduce the timeline for drug development, and increase accessibility to therapeutics that prolong life. healthy lifespan, also known as lifespan. A Riyadh-based non-profit organization with an annual budget of up to $1 billion, the Hevolution Foundation plans to open centers in North America and other global locations to support a global ecosystem of cutting-edge talent to to propel research on aging and geroscience. and achieve medical breakthroughs to help humanity live healthier, longer lives.
The American Federation of Research on Aging (AFAR) is a national, nonprofit organization that supports and advances pioneering biomedical research that is revolutionizing the way we live longer, healthier lives. For more than four decades, AFAR has served as an incubator for talent in the field, providing more than $189 million to more than 4,300 researchers at leading research institutes across the country. A trusted leader and strategist, AFAR also works with public and private funders to drive high-quality grantmaking programs and interdisciplinary research networks. AFAR-funded researchers discover that altering basic cellular processes can delay or even prevent many chronic diseases, often at the same time. They’re discovering that it’s never too late — or too early — to improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and prolong our quality of life, at any age. Learn more about www.afar.org or follow AFARorg on Twitter and Facebook and American Federation for Aging Research on LinkedIn.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220830006038/en/
Media contact for the Hevolution Foundation:
Media & Communication Manager